Temporal trends in stroke admissions in Denmark 1997–2009 by Malene Nøhr Demant et al.
Demant et al. BMC Neurology 2013, 13:156
http://www.biomedcentral.com/1471-2377/13/156RESEARCH ARTICLE Open AccessTemporal trends in stroke admissions in Denmark
1997–2009
Malene Nøhr Demant1*, Charlotte Andersson1, Ole Ahlehoff1, Mette Charlot1, Jonas Bjerring Olesen1, Anne Gjesing1,
Peter R Hansen1, Gunnar H Gislason1, Thomas Truelsen2 and Christian Torp-Pedersen3Abstract
Background: The Stroke burden is increasing in many populations where health institutions may experience more
patients. We wanted to examine whether incidence rates and absolute number of hospitalized stroke patients
remained stable in Denmark during a 13 years period where exposure to major stroke risk factors decreased,
changes in stroke treatment was implemented, and the age of the population increased.
Methods: The Danish National Patient Register was used to identify all subjects 25 years of age or above admitted
with a first time stroke in Denmark from 1997–2009. Incidence rates (IRs) and age-adjusted Poisson regression analyses
were used to examine trends in age-, gender- and stroke subtype (ischaemic or unspecified).
Results: During the 13-year observation period there were 53.5 million person-years at risk (PY) and a total of 84,626
male and 84,705 female stroke patients were admitted to Danish hospitals. The IRs of hospitalized strokes per 1000 PY
was 3.21 (95% confidence interval [CI] 3.16-3.27) in 1997, 3.85 (95% CI 3.79-3.91) in 2003 and 3.22 (95% CI 3.16-3.28) in
2009, respectively.
Incidence rate ratios of hospitalized stroke events adjusted for age in the period 2007–2009 compared to 1997–2000
were 0.89 (95% CI 0.87- 0.91) for men and 0.92 (95% CI 0.90-0.94) for women.
The incidence of hospitalized unspecified strokes decreased from 1997 to 2009 whereas there was a steep rise in
incidence for hospitalization with specified ischemic stroke during this period.
Conclusion: This study found a constant rate of stroke hospitalization in Denmark from 1997–2009. The overall rate of
hospitalized strokes adjusted for age decreased during this period.
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Stroke is a leading cause of death and acquired adult
disability and it is estimated that globally each year 5.8
million people die from stroke [1]. In high income
countries it has been stated that approximately 1 in 20
adults is affected by stroke and the incidence of acute
cerebrovascular events (strokes and transient ischemic
attack combined) exceeds the incidence of acute coronary
heart disease [2]. In the recent INTERSTROKE study
five risk factors including hypertension, current smoking,
abdominal obesity, diet and physical activity, were
associated with 80% of the global risk of stroke and* Correspondence: malenedemant@gmail.com
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reproduction in any medium, provided the orinterventions to reduce these factors are therefore likely to
reduce the stroke incidence [3]. The observation period in
this study covers a time period where smoking prevalence
among Danes in general declined and treatment of
hypertension and hypercholesterolemia gradually improved
[4,5]. During the same period life expectancy and mean
age of the population increased which could be followed
by a higher absolute number of stroke events. Increasing
life expectancy and mean age of the population would
therefore be likely to increase the absolute number of
stroke events. Different trends in stroke incidence have
been reported worldwide, and it is currently not known
if the stroke incidence has changed in Denmark [6-9].
Temporal changes in admission and diagnostic practices
may tend to increase the overall hospitalization rates,
which is a burden to health facilities even if it does notl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Comorbidity ICD codes
Comorbidity ICD codes
Heart failure ICD-8: 427, 428
ICD-10: I42, I50, I110, J819
Ischaemic heart disease ICD-8: 411, 412, 413, 414







ICD-8: 490, 491, 492
ICD-10: J42, J44
Atrial fibrillation ICD-8: 427.4
ICD-10: I48
Acute myocardial infarction ICD-8: 410
ICD-10: I21, I22




Hypertension ICD-8: 400, 401
ICD-10: I109, I119, !959, I270, I951
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Therefore the aim of this study was to examine temporal




All Danish residents have a unique civil registration
number in the Danish Civil Registration System that
enables individual level-linkage between nationwide
registries. This study was based on The Danish National
Patient Registry which registers all hospital discharge
diagnoses since 1978. At discharge all admissions are
registered by one primary and if appropriate one or
more secondary diagnoses according to the International
Classification of Disease, the 8th revision (ICD-8) from
1978 to 1994 and the 10th revision (ICD-10) from 1994.
Population and demographics
The population demographics used in Table 1 was based
on a stroke population and a control population that
included all Danish citizens who were alive and older
than 25 years as of January 1st 1997. The stroke population
included individuals registered with a first diagnosis
of stroke during the period from January 1st 1997 to
December 31st 2009 and the control population in-
cluded individuals with no stroke diagnosis during the
period from January 1st 1997 to December 31st 2009.
All individuals with previous stroke diagnosis, defined
as having a primary or secondary diagnosis of stroke
(all types) from January 1st 1978 to January 1st 1997,
were excluded.
Outcome
The study endpoint was stroke (all types, primary as well
as secondary diagnoses) and further stratified according
to subtype of stroke as unspecified stroke: 436 (ICD-8)
and I64.9 (ICD-10) or ischemic stroke: 433, 434 (ICD-8)
and I63 (ICD-10). Intracerebral hemorrhage (ICH): 431
(ICD-8) and I61 (ICD-10) and subarachnoidal hemorrhage
(SAH): 430 (ICD-8) and I60 (ICD-10) were included in
“all types of stroke”. Patients were followed until death or
end of the study period i.e. December 31st 2009.
Comorbidity
Information about preexisting conditions and past hos-
pitalization was obtained from discharge diagnosis from
The Danish National Patient Registry [10]. The comorbidity
diagnoses for the stroke population were defined by
presence of such diagnoses any time prior to, or on the
day of the stroke. The comorbidity diagnoses for the
control population were defined as whether or not they
had such diagnoses any time prior to, or on July 1st2002 i.e. after half of the study period. Codes of comor-
bidities are shown in Table 1.
Statistical analysis
Categorical data are presented as numbers (percentages)
and continuous variables are presented as mean with
standard deviation. The number of all types of strokes,
unspecified strokes and ischaemic strokes were obtained
for each year from 1997–2009. Age specific incidence
rates (IRs) for stroke admissions for each decade of age
were calculated by dividing age-specific stroke cases by
age-specific population sizes each year from the Danish
Civil Registration System. The rates were stratified by
gender and year of occurrence.
The study period was divided into 4 periods (1997–2000,
2001–2003, 2004–2006 and 2007–2009) and further
into 6 age groups (25–45, 45–54, 55–64, 65–74, 75–84
and > 84 years). Calculations of changes in stroke incidence
during the four periods were based on Poisson-regression
analysis. We used a dynamic cohort population where
individuals could move to a higher age-category during
the follow-up period. To further adjust for the confounding
effect of age each stratum was adjusted for age as a
continuous variable (i.e., age in whole years). No interaction
tests were done.
For all analysis a p-value of < 0.05 was considered
statistically significant. The statistical packages SAS 9.2
Table 2 Demographic characteristics
Stroke population Control population
N = 167840 N = 3433729
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version 11 (StataCorp, college St. TX, USA) were used
for the analysis.Age (years) 71.9 ± 13.2 54.4 ± 16.3
Gender (% women) 50.0% 51.5%
Heart failure 19723 (11.6%) 113840 (3.3%)
Ischemic heart disease 27446 (16.4%) 154833 (4.5%)
Anemia 9231 (5.5%) 52759 (1.5%)
Cancer 25259 (15.1%) 239197 (7.0%)
COPD 11347 (6.8%) 81976 (2.4%)
AF 20960 (12.5%) 68170 (2.0%)
AMI 16865 (10.1%) 101040 (2.9%)
PAD 7778 (4.6%) 32157 (0.9%)
DM 16841 (10.0%) 80242 (2.3%)
Hypertension 33901 (20.2%) 111727 (3.3%)
COPD = chronic obstructive pulmonary disease, AF = atrial fibrillation, AMI =
acute myocardial infarction, PAD = peripheral arterial disease, DM = diabetesResults
Demographic characteristics
From January 1st 1997 to December 31st 2009 167,840
admissions for first strokes were identified in the main
study population of 3,601,569 persons. A total of 61,331
persons were excluded due to previous stroke diagnosis.
There was equal distribution of strokes between men
and women. Among all strokes 49.5% were classified as
unspecific, 38.3% as ischaemic, 4.6% as SAH and 7.6% as
ICH. The mean age at the time of first stroke was 71.9
(standard deviation 13.2) years.
Figure 1 shows a flowchart of the selection of the
study population and demographic characteristics are
summarized in Table 2.mellitus. Data are means (standard deviations).Hospitalization for first time stroke 1997–2009
The total unadjusted IRs per 1000 PY were 3.21 (95%
confidence interval [CI] 3.16-3.27) in 1997, 3.85 (95% CI
3.79-3.91) in 2003 and 3.22 (95% CI 3.16-3.28) in 2009.
Figure 2 shows age- and gender stratified IRs for all
types of strokes.
In general, stroke incidence increased with each decade
of patient age.Figure 1 Flowchart of study population.During the 13-year observation period of 53.5 million
person-years (PY) a total of 84,626 and 84,705 admissions
for first stroke were registered in men and women,
respectively.
Results from the Poisson regression analysis adjusted
for age for all types of strokes are shown in Figure 3.
Throughout the study period a significant decrease in
risk was seen in the age groups 55–64, 65–74, 75–84
and > 84 years among men, and in the age groups 55–
64, 65–74 and 75–84 years among women, whereas an
increase in risk was seen the age group < 45 years among
men and in the age groups < 45 and 45–54 years among
women, in 2007–2009 compared to 1997–2000.
Adjusted for age the incidence rate ratios (IRRs) for
stroke associated with the time period 2007–2009 were
0.89 (95% CI 0.87-0.91) for men and 0.92 (95% CI 0.90-
0.94) for women compared with the time period 1997–
2000.Changes in stroke hospitalization rates according to
stroke subtypes
Figure 4 shows age- and gender-stratified IRs for un-
specified strokes and ischaemic strokes. Figure 5 shows
stroke IRRs for men and women for unspecified strokes
and ischaemic strokes.
For unspecified stroke a small increase in IRs was seen
for men from 1997–1999, but hereafter a steep decline
in IR occurred. This pattern was also seen for women.
The IRRs for unspecified stroke decreased from the
time period 1997–2000 compared to the time period
2007–2009 in both genders in all age groups, except in
the age group < 45 years in women.
Figure 2 Incidence rates, all types of stroke. Age- and gender stratified incidence rates (with 95% confidence intervals) of hospitalization with all
types of stroke in Denmark 1997–2009. A shows incidence rates for all types of stroke for men, B shows incidence rates for all types of stroke for women.
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both men and women from 1997 to 2009. For all age
groups and both genders a significant increase in IRRs
for ischemic stroke were seen for all time periods com-
pared to 1997–2000.Figure 3 Incidence rate ratios, all types of stroke. Stroke incidence rate
time periods with 1997–2000 as reference. Poisson regression model. A sho
incidence rate ratios for all types of stroke for women.Discussion
This nationwide study showed that in the Danish popu-
lation there was a constant rate of hospitalized stroke
events of 3.2/1000 PY from 1997–2009. A decrease in
the stroke hospitalization rate was seen when adjustedratios (with 95% confidence interval) for all types of stroke during 4
ws incidence rate ratios for all types of stroke for men, B shows
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during the study period whereas the IRs for hospitalized
unspecified stroke decreased. Compared to the control
group the stroke population was generally older and
suffered from more comorbid conditions.
Different trends in stroke incidence have been reported
previously in different countries. In a systematic review
of 56 population-based studies from 2009, based onFigure 4 Incidence rates, unspecified and ischemic stroke. Age- and g
hospitalization with unspecified and ischemic stroke in Denmark 1997–2009. A
rates for unspecified stroke for women, C shows incidence rates for ische
for women.multiple sources of information, the authors reported a
42% decrease in stroke incidence in high-income countries,
and a more than 100% increase in low to middle income
countries [7]. The World Health Organization (WHO)
Monitoring Trends And Determinants In Cardiovascular
Disease (MONICA) stroke project did not report a defin-
ite change in stroke incidence over time [9]. Multinational
comparison is possible with appropriate data qualityender stratified incidence rates (with 95% confidence intervals) of
shows incidence rates for unspecified stroke for men, B shows incidence
mic stroke for men and D shows incidence rates for ischemic stroke
Figure 5 Incidence rate ratios, unspecified and ischemic stroke. Stroke incidence rate ratios (with 95% confidence interval) for unspecified
strokes and ischemic strokes during 4 time periods with 1997–2000 as reference. Poisson regression model. A shows incidence rate ratios for
unspecified strokes for men, B shows incidence rate ratios for unspecified strokes for women, C shows incidence rate ratios for ischemic strokes
for men and D shows incidence rate ratios for ischaemic strokes for women.
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The Copenhagen City Heart Study, a prospective study
based on discharge diagnosis as well as supplementary
patient files, found that stroke incidence from 1976–
1993 remained stable among men aged 45–64 years
and women aged 45–84 years, whereas a statistically
significant decrease was found in men aged 65–84 years[12]. Similarly, another Danish prospective study based on
clinical stroke diagnoses evaluated by a trained neurolo-
gist, in the community of Frederiksberg, Copenhagen,
found an increase of 42% in stroke incidence for men aged
65–84 years from 1972–1974 to 1989–1990 [13]. There
were no changes in IRs for women. In Lund, Sweden,
in a study involving retrospective screening of medical
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people < 75 years of age [14]. In a recent cohort study
from Rotterdam, the Netherlands, based on stroke
diagnosis from general practitioners as well as hospital
files reviewed by a stroke neurologist, the authors found
that IRs from 1990–2008 increased in men, but not in
women [15].
The observation period in this study covered a time
period where smoking prevalence among Danes in general
declined and treatment of hypertension and hyperchol-
esterolemia gradually improved [4,5]. On the other hand
the incidence of atrial fibrillation (AF) is likely to have
increased, partly due to increasing population size as
well as a larger proportion of elderly [16,17]. AF is an
important risk factor for stroke and is estimated to be
associated with approximately 1/5 of ischaemic stroke
events, which could increase in the absolute number of
stroke events due to the rise in AF incidence [18,19].
Furthermore, it has been suggested that an increase in
stroke occurrence might be due to increased survival
after ischaemic heart disease [20]. Increased focus on
and awareness of stroke symptoms in both the general
population and in the health care system may lead to
improved detection of less-severe strokes and which
could increase the number of patients discharged with
a diagnosis of stroke [21]. Introduction of thrombolytic
treatment given to carefully selected patients may have
further increased the focus on early recognition and
diagnosis of stroke events, as the chances of successful
outcome decrease by the minute after onset of stroke
symptoms [22,23]. This may also have resulted in a ten-
dency in the current era to perform cerebral CT scanning
of patients with milder cases of strokes, which would not
have been diagnosed before. As such, the fact that the
number of patients diagnosed with ischaemic stroke
increased over time in our study may be explained, in
part, by increased use of cerebral imaging procedures.
During the later years more hospital units have gained
access to CT and MRI scanners that make it more likely
that the stroke diagnosis has become more specific. There-
fore, the increasing IRs of ischaemic strokes observed in
our study is more likely to reflect the implementation of
scanners in the Danish health care system than an actual
increase in actual ischemic stroke rates. This notion
may also explain why the IRs of patients admitted with
unspecified stroke decreased in the observed time
period. The decreasing rates may again reflect that
more and more patients are scanned and may therefore
receive a more exact stroke diagnosis.
Recent WHO estimates based on reviews of studies
including more than 20 million subjects, project that
the number of strokes in European countries is likely to
increase from 1,1 million per year in 2000 to 1,5 million
per year in 2025 [24]. Moreover, the median age in thesepopulations is envisioned to rise from 37.7 years in 2000
to 47.7 years in 2050 along with a decrease in the total
number of Europeans. Overall, these projections suggest
that the absolute number of strokes will increase in future
decades, whereas the number of younger adults will
decrease. This development is likely to put further burden
on the welfare society and health care systems in European
countries [25,26].
This study reflects the number of patients discharged
from hospital and every patient admitted for a stroke
calls for hospital facilities as well as urgent attention
from physicians and nurses. The large group of patients in
need of assistance and rehabilitation is also a significant
expense for the health care system as half of all stroke
patients suffer from permanent ill-effects and almost
one-out-of-four acquire disabilities to such an extent that
help to everyday activities is necessary [27]. Furthermore
there is an additional cost due to the decreased employ-
ability and early retirement of stroke patients, as well
as the fact that one third of all stroke patients suffer
from depression [28]. The socioeconomic importance
of the disease cannot be underestimated.
Strengths and limitations
This was a retrospective register based study only includ-
ing hospitalized cases of strokes. Caution is therefore
required when making conclusions regarding the true
IRs of strokes in Denmark as several factors may impair
the use of hospital discharge diagnoses for direct disease
analysis. Registers are vulnerable to changes in registration
practices, which may alter the sensitivity and specificity of
the diagnosis. For example, studies have shown that a
stroke discharge diagnosis from a specialized neurology
unit had a higher positive predictive value than a stroke
diagnosis from emergency rooms [29]. This may reflect a
greater expertise, routine and interest in the treatment
and diagnosis of stroke patients in specialized units, along
with the fact that emergency rooms often have much less
time before the patient is transferred to other units, and
may not have had time to evaluate neuroimaging results.
The validation of stroke discharge diagnosis in The Danish
National Patient Registry has also been shown to differ
substantially among stroke subtypes, and the register
appears to generally overestimate the number of strokes
[29,30]. Indeed, while two studies from 2001 and 2007
showed positive predictive values of 88% and 98% for
the ischaemic stroke diagnosis, respectively, the majority
(60%) of unspecified strokes was identified in cases di-
agnosed with ischaemic strokes and 5% of unspecified
strokes were identified in cases diagnosed with ICH
[29,30]. In addition the Danish National Patient Registry
contains no information on smoking status and body mass
index and no adjustments were therefore made for these
stroke risk factors.
Demant et al. BMC Neurology 2013, 13:156 Page 8 of 8
http://www.biomedcentral.com/1471-2377/13/156Conclusion
This study found a constant rate of stroke hospitalization
from 1997–2009. The overall rate of stroke hospitalized
stroke events adjusted for age was reduced during the
study period. This study was the first to investigate
trends in patients discharged with a first-time stroke
diagnosis in Denmark. Effective preventive and treatment
strategies are very much needed, as the burden of stroke
will increase as the elderly segment of the population
increases.
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